Depotwettbewerb USA 20 KW

mein Posting 3) wird aktuell.

IGLD hat vorbörslich Zahlen geliefert,die nicht so toll waren.Denke,die gehen heute rund 20% in die Knie(wie gestern PCNTF).Deshalb mein SL 5.50(ist vor börslich auch Umsatz).

                                       revenues of $4.6 million and a net loss of
                                       $4.1 million, or $0.16 per share (including
                                       restructuring costs of $2.7 million, or $0.10
                                       per share), in the fourth quarter of 2002.

                                       Software license revenues for the first quarter
                                       of 2003 were $2.2 million, while service
                                       revenues were $2.9 million. This compares to
                                       software license revenues of $1.0 million and
                                       service revenues of $2.1 million in the first
                                       quarter of 2002, and software license
                                       revenues of $2.4 million and service
revenues of $2.2 million in the fourth quarter of 2002.

Gross profit in the first quarter of 2003 was $3.3 million, or 64% of revenues, compared to $1.7
million, or 54% of revenues, in the same period last year, and $2.8 million or 61% of revenues in
the fourth quarter of 2002.

Net cash from operating activities was a positive $2.0 million in the first quarter of 2003,
compared to a negative $0.3 million in the fourth quarter of 2002. The company increased its
cash reserves (cash, cash equivalents and short and long-term investments) by $2.0 million from
December 31, 2002. As of March 31, 2003, the company had cash, cash equivalents, and short
and long-term investments of $8.6 million. Total assets at the close of the quarter were $14.4
million and stockholders' equity was $6.9 million. Number of company's employees as of March
31, 2003 was 112. This means revenues of $46,000 per employee for the quarter, or roughly
$184,000 on an annualized run-rate.

"The results for the first quarter of 2003 signify two important milestones for ClickSoftware," said
Dr. Moshe BenBassat, ClickSoftware's Chairman and Chief Executive Officer. "First, we reached
profitability, and second, we started to generate cash again. While the economy continues to be
challenging, we believe that with the cost-cutting measures we took last year and continued
demand for our products we will be able to sustain this trend."

ClickSoftware signed five new clients in the first quarter: two in Europe, two in North America,
and one in New Zealand. The company continued to expand in the utility market with major wins
of National Grid in the UK and Pacific Corporation in the U.S. In New Zealand the company won
Fisher & Paykel, a leading vendor and service provider of home appliances. The company also
had significant repeat orders, primarily for additional licenses, as existing customers continue to
roll out ClickSoftware's solutions.

"We continue to strengthen our relationships with our strategic partners; e.g., National Grid is a
joint project with Accenture. Overall the percentage of deals that are influenced by our strategic
partners is increasing. Looking forward, we believe that we will be able to sustain similar levels of
revenues in the upcoming quarters," added Dr. BenBasssat.
chart.bigcharts.com/bc3/quickchart/...93&mocktick=1&rand=4084" style="max-width:560px" >

tatsächlich schon unter 5,--.Gut,dass es SL gibt.

chart.bigcharts.com/bc3/quickchart/...33&mocktick=1&rand=7678" style="max-width:560px" >

Eigentlich müßte hier jeder jeden ab und zu gratulieren.
Heute wäre der Doc mit seinen NANX + ALTI an der Reihe.
Also, Glückwunsch Doc!
Schon not bad, watt hier die wenigen Spieler an Glück, richtiger Nase, Infos und Aktienvorschlägen bringen.
So soll datt ja auch sein.
Doc, diese Runde "könnte" aufgrund der Bestückung deines Depot`s trotz meiner AVNX noch eindeutig an dich gehen.
Jedenfalls rückt datt kleine Feld wahrscheinlich etwas dichter zusammen.
Ok, Henri bildet die Spitze und der Rest datt breite Mittelfeld.
Mir macht es hier jedenfalls noch Spass, genauso wie im richtigen Leben.
Es klappt mit den Aktien zwar nicht immer, aber immer öfter.
;-)
Schaut doch auch ma eine SIRI und EURO an.
PROX strahlt auch noch, ich träume von 3 Dollar.
;-)
Also, ich wünsch euch watt!

                                      Gr.Gr.

herzlichen Dank für das "Mittelfeld".Zur Zeit bin ich nur Abstiegsplatz.

Moin!
Da mir meine Gewinne jetzt förmlich langsam flöten gehen, muss ich leider watt machen.
Um noch watt zu retten, werden also 6 meiner 10 Zocker- Werte auf SK- Basis 14.05.03 verkauft.

AVNX  KK 1,12  akt. 2,70  = Plus 141%  = Dollar 12142
PNFT  KK 1,26  akt. 1,69  = Plus 34%   = Dollar 6757
BIOM  KK 1,23  akt. 1,42  = Plus 15,5% = Dollar 5815
-MDR  KK 5,08  akt. 6,31  = Plus 24,5% = Dollar 6260
GENR  KK 0,66  akt. 0,67  = Plus 1,5%  = Dollar 5113
-WEL  KK 0,52  akt. 0,51  = Minus 2%   = Dollar 4940

Damit habe ich 41027 Dollar Cash und noch ROBV, BDAL, SPPI und DOC im Depot.

Am Wochenende wird wieder wie gewohnt ein neues gruenes Absacker- Depot aufgestellt.

Euch noch viel Erfolg bis dahin wünscht

                                            Gruenspan


                     

Saubere Performance, meine neidlose Anerkennung !

Greetz f-h

Datt mußte ja so kommen.
GENR verkauft und prompt machen die über 30%!

Henri, meine noch verbliebenen Depot- Hänger werden die Wochenabrechnung mächtig drücken.
Deine CHTR, AV und ETS schauen dagegen noch blendend aus.
Der DOC hat wohl diesmal die beste Performance!
Da kriegen sogar die STAA und GTI nach NANX und ALTI richtig Höhenluft.
Hut ab, not bad.
Bei Pavian machen LJPC mächtig Musik und bei Eski weiterhin die UBET!
Gute Karten hat also irgendwie jeder, nur ich muss aufgrund meiner Aktivitäten hier immer NEUE suchen.

                          Gr.Gr.

                             

auch nich jeder, eine Aktie (GENR) zu verkaufen, welche am Folgetag 60% Kursplus macht, nur weil ich vergessen, bzw. übersehen hatte, datt die ja eine Präsentation vor hatten.
Gruenes Leid- pur!
;-(((

             Gruß Pechspan

CHARTER COMMUNICATIONS A - Nasdaq National Market: CHTR
Consolidated Real-time Market Quote*

Last	Change (%)	After Hours Chg (%)**	Bid	Ask	Trade Time
2.465	quotes.freerealtime.com/gra/uparrow1.gif" style="max-width:560px" > 0.395 (19.08)	N/A	2.452 (5)	2.477 (11)	10:11

---

Exchange Quote

Last	Change (%)	Bid (size)	Ask (size)	Trade Time
2.38	quotes.freerealtime.com/gra/uparrow1.gif" style="max-width:560px" > 0.31 (14.98)	2.37 (190)	2.38 (30)	09:54
Day Volume	Last Size	Open	High	Low
5,796,886	1,000	2.20	2.40	2.06
Latest Ticks	# of Trades	Avg Trade Size	VWAP	52 Wk High
==-+	3,061	1,894	2.2936	8.66
52 Wk Low	Prev Close	Avg Day Vol
0.76	2.07	8,512,800

CHTR hatte ich zu 0,98 Dollar hier auch schon im Spiel.
Schöner Treffer wäre datt gewesen.
Selbigen hast du nun wie schon öfters gelandet.
Da sind mal wieder Glückwünsche angesagt!


         

               
                                   Gr.Gr.;-)

Women First HealthCare markets Esclim to target physicians across the United States, primarily OB-GYN's who prescribe hormone therapy for women in menopause. The company has achieved success in making Esclim available on health plans via coverage by Pharmacy Benefit Managers (PBM's), which manage prescription benefits for health plans and employee groups. Medco Health Solutions, the largest such group, provides benefits for over 65 million members via 12 home delivery pharmacies and a nationwide network of more than 58,000 retail pharmacies.

Women First HealthCare markets Esclim exclusively in the U.S. under a distribution and licensing agreement with Laboratories Fournier SA of France. Esclim is approved by the U.S. Food and Drug Administration (FDA) for the treatment of vasomotor menopausal symptoms such as hot flashes and night sweats. The Esclim transdermal patch system offers maximum dosing flexibility with five dosage options (0.025, 0.0375, 0.05, 0.075, and 0.1 mg/day) and is applied to the skin twice weekly. Esclim provides a unique ethylene vinyl acetate (EVA) matrix system with flexible foam backing to assure suppleness that follows the movement of a woman's skin.

About Women First HealthCare, Inc.

Women First HealthCare, Inc. (NASDAQ: WFHC, news) is a San Diego-based specialty pharmaceutical company. Founded in 1996, its mission is to help midlife women make informed choices regarding their health care and to provide pharmaceutical products -- the Company's primary emphasis -- and lifestyle products to meet their needs. Women First HealthCare is specifically targeted to women age 40+ and their clinicians. Further information about Women First HealthCare can be found online at www.womenfirst.com, About Us and Investor Relations.

About Esclim

Esclim is indicated for the relief of moderate to severe vasomotor symptoms associated with menopause.

The most commonly reported side effects of Esclim are those typical of estrogen therapy: breast tenderness, headache, nausea, and abdominal pain. Estrogens have been reported to increase the risk of endometrial carcinoma in postmenopausal women. Estrogens are contraindicated in patients with known or suspected pregnancy, undiagnosed abnormal genital bleeding, known or suspected breast cancer, known or suspected estrogen-dependent neoplasia, or active thrombophlebitis or thromboembolic disorders. For more information about this product and to see the package insert, please visit www.womenfirst.com, Rx Products area.

This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are often, but not always, made through the use of words or phrases such as "believe," "will," "expect," "anticipate," "estimate," "intend," "plan," and "would." Such forward-looking statements are subject to various risks, and Women First HealthCare, Inc. cautions you that any forward-looking information is not a guarantee of future performance. Women First HealthCare, Inc. disclaims any intent or obligation to update these forward-looking statements. Actual results could differ materially due to a number of factors, including (i) we may not maintain compliance with the new covenant levels established with respect to the senior secured notes; (ii) we have incurred significant losses since we were founded in November 1996, and if midlife women do not use, and their clinicians do not recommend, the products we offer, we will experience losses in the future; (iii) there is a limited market awareness of our Company and the products and services we offer; (iv) we may not be able to identify appropriate acquisition, licensing, or co-promotion candidates in the future or to take advantage of the opportunities we identify; (v) we and our products face significant competition; (vi) our products may not achieve or maintain market acceptance for a variety of reasons, including as a result of recent research published by the National Cancer Institute and the National Institutes of Health concerning estrogen replenishment therapy and combination estrogen/progestin hormonal replenishment therapy in healthy menopausal women, respectively; (vii) if we do not successfully manage any growth we experience, we may experience increased expenses without corresponding revenue increases; (viii) we are dependent on single sources of supply for all of the products we offer; (ix) reduced consumer confidence could adversely affect sales by our Consumer Business Division; (x) our third party suppliers and licensors may terminate their agreements with us earlier than we expect, and as a result we may be unable to continue to market and sell the related pharmaceutical products on an exclusive basis or at all; (xi) if we overestimate demand for our products, we may be required to write off inventories and/or increase our reserves in future periods, (xii) we have incurred significant debt obligations which will require us to make debt service payments in the future; and (xiii) additional factors set forth in the Company's Securities and Exchange Commission filings including its Annual Report on Form 10-K for the period ended December 31, 2002.



   CONTACT: Women First HealthCare, Inc., San Diego
            Charles M. Caporale, Vice-President, CFO, 858/509-3806
            ccaporale@womenfirst.com

ich habe bei Yahoo-unter den messages bei MIR-zufällig gelesen,dass sich die Vorstände mächtig mit Aktien eingedeckt haben sollen; ca.8.0 Mio Shares. Würde für den Wert sprechen.

Zur Performance-hallo Doc,Grueni und f-h-muss man nicht mehr viel sagen.

Bin auch stolz auf SEAC,diese Woche immerhin 25% up,aber leider ist das mein Wert mit dem geringsten Depotvolumen.

Ich gehe davon aus,dass am Wochenende disponiert werden kann.Ich bin mit IGLD ausgestoppt worden: 1.500 Shares Sl 5.50 (mein SL),so dass ich auf 8.250,-- Cash sitze.

Bis gleich oder morgen Ciao B.L.

aber MCLD hatte ich so bei 0.55 verkauft(vor 6 Wochen ca.),heute 1.00 Dollar.

Timing,Timing.....

Hab irgendwie Lust hier rumzuzocken.
IGLD ist ein israelisches Unternehmen, noch eins ist VIZRT, früher Rt-Set Real, gabs
ja ein bisschen was zu lesen heute auf ARIVA.
Ich melde Viryanet aus Israel für den Depotwettbewerb an, obwohl die an der NASI kaum gehandelt werden.

Bis später, Gruss E.

chart.bigcharts.com/bc3/quickchart/...72&mocktick=1&rand=3311"
 
 
  Kurshistorie NASDAQ  VRYA
  Datum Erster  Hoch  Tief  Letzter  Umsatz  
 15.05.2003   0,580   0,970   0,580   0,770   56.050  
 14.05.2003   0,520   0,580   0,520   0,580   23.390  
 13.05.2003   0,500   0,500   0,500   0,500   100  
 12.05.2003   0,460   0,460   0,460   0,460   0  
 09.05.2003   0,470   0,470   0,460   0,460   6.400  
 08.05.2003   0,520   0,520   0,520   0,520   0  
 07.05.2003   0,520   0,520   0,520   0,520   0  
 06.05.2003   0,520   0,520   0,520   0,520   0  
 05.05.2003   0,520   0,520   0,520   0,520   0  
 02.05.2003   0,520   0,520   0,520   0,520   100  
 01.05.2003   0,470   0,520   0,470   0,520   3.400  
 30.04.2003   0,470   0,470   0,460   0,470   6.900  
 29.04.2003   0,440   0,470   0,440   0,470   5.600  
 28.04.2003   0,440   0,440   0,440   0,440   2.000  
 25.04.2003   0,440   0,440   0,440   0,440   0  
 24.04.2003   0,440   0,440   0,440   0,440   0  
 23.04.2003   0,440   0,440   0,440   0,440   3.000  
 22.04.2003   0,490   0,490   0,420   0,420   2.100  
 21.04.2003   0,500   0,500   0,500   0,500   0  

Die Regel ist eindeutig. Ein Kauf wird immer mit 10% unter SL abgesichert. Wenn der Share steigt, kann man den SL hochziehen, maximal aber bis 10% unter Schlusskurs Freitag, nicht höher.
Wenn Du also für 10 kaufst, ist Dein SL mindestens 9,10.
Wenn dann in der laufenden Woche der betreffende Share bei 9,20 schliesst, bleibt Dein SL bei 9,10 und Du kannst überlegen ob Du drinbleibst.
Wenn der Share allerdings auf 12 Dollar gestiegen ist, ist Dein SL maximal 10,80, ist eindeutig meine ich.
Leider weiss ich nicht genau wegen meines Urlaubs, wie die Schlussstände von IGLD an den Freitagen waren.
Also, IGLD fliegt für Dich bei 5,50, danach gibts keine Kompromisse mehr, die  Stop-Loss Regel ist jetzt ausreichend erläutert.
Es ist immer wieder nett, nach den vielen alten Shares zu sehen, die der eine oder andere im Depot hatte.
So spontan fällt mir Royal Gold ein, hatte reinyboy glaub ich so bei 13 weggetan oder meine SCHK aus der 4 KW. Macromedia hatte ich bei 12,30 gekauft vorm Urlaub, Deine MCLD, etc...

Gruss E.

chart.bigcharts.com/bc3/quickchart/...26&mocktick=1&rand=4399"


chart.bigcharts.com/bc3/quickchart/...95&mocktick=1&rand=2122"


chart.bigcharts.com/bc3/quickchart/...10&mocktick=1&rand=4861"

das ist immer so ein Problem vor den Zahlen.Hatte SNIC(Zahlen eigentlich ganz okay,aber danach Sell off) und IGLD(Zahlen so la la,erst recht Sell off).Also zukünftig entscheide ich im Sinne der obigen Regeln.

AETH, SWC, SOI, VRYA.

Werd ich alle irgendwie einbauen,

Gruss E.

mal schauen, bekommst Du die Abrechnung heute noch hin, Eskimato ?

Greetz f-h

Kommt eigentlich gegen 23.30 Uhr. Um 24 Uhr mache ich auf jeden Fall Feierabend,
wahrscheinlich morgen.
Seit wann hast Du eigentlich ASKJ im Depot?

Gruss E.

chart.bigcharts.com/bc3/quickchart/...56&mocktick=1&rand=7211"

hatte sie schon mal.

Greetz f-h

Keine Mail gekommen, Mist.

Tschüss bis morgen, E.

Was soll ich denn damit tun, Server bei denen im A.., Hilfe.

my Watchlist closing prices

Symbol Last Change (%) Volume
AES  0 0 (0.00) 0
AGAM  0 0 (0.00) 0
ALTI  0 0 (0.00) 0
AMKR  0 0 (0.00) 0
ASKJ  0 0 (0.00) 0
ATRS  0 0 (0.00) 0
AV  0 0 (0.00) 0
BAXS  0 0 (0.00) 0
BDAL  0 0 (0.00) 0
BEV  0 0 (0.00) 0
CHTR  0 0 (0.00) 0
DCRN  0 0 (0.00) 0
DOC  0 0 (0.00) 0
ETS  0 0 (0.00) 0
EVOL  0 0 (0.00) 0
FLML  0 0 (0.00) 0
GENE  0 0 (0.00) 0
GERN  0 0 (0.00) 0
GSS  0 0 (0.00) 0
GTI  0 0 (0.00) 0
HGR  0 0 (0.00) 0
IGLD  0 0 (0.00) 0
KANA  0 0 (0.00) 0
LJPC  0 0 (0.00) 0
MIR  0 0 (0.00) 0
MRBA  0 0 (0.00) 0
MTLG  0 0 (0.00) 0
NANX  0 0 (0.00) 0
NENG  0 0 (0.00) 0
OPSW  0 0 (0.00) 0
PDYN  0 0 (0.00) 0
PRCP  0 0 (0.00) 0
PRTL  0 0 (0.00) 0
REDF  0 0 (0.00) 0
ROBV  0 0 (0.00) 0
SEAC  0 0 (0.00) 0
SPPI  0 0 (0.00) 0
SSFT  0 0 (0.00) 0
STAA  0 0 (0.00) 0
UBET  0 0 (0.00) 0
VISG  0 0 (0.00) 0
WFHC  0 0 (0.00) 0
XOMA  0 0 (0.00) 0

Click here to Unsubscribe